The Department of Veterans Affairs (VA) seeks radiopharmaceuticals for the Syracuse VA Medical Center in New York. The combined synopsis and solicitation document outlines a requirement for a firm fixed-price contract to supply these pharmaceuticals, with a focus on meeting the center's needs.
The scope of work involves the provision of radiopharmaceuticals and associated services, with the potential for renewal options. The VA emphasizes the need for timely delivery and the ability to fulfill sudden increases in demand.
Eligible applicants should have a strong track record in pharmaceutical manufacturing, with the NAICS code 325412 and a corresponding size standard of 1,300 employees. To demonstrate their ability to meet the VA's requirements, bidders must submit comprehensive quotes outlining their capabilities.
Funding for this unrestricted opportunity is estimated at $600,000 to $700,000. The contract type is a firm fixed price contract, and the submission deadline is available in SAM.gov.
The VA will evaluate bids based on their compliance with the requirements, considering past performance, price, and delivery timelines.
Interested parties should direct any inquiries to Morgan Weeks at Morgan.Weeks1@va.gov or via phone at (607) 664-4708.
This summary provides an overview of the VA's radiopharmaceutical contract opportunity, combining information from the government listing and associated files. For more details, prospective bidders are advised to refer to the full solicitation document and SAM.gov.